LABORATORY NEWS
-
PixCell Medical Expands Into Canada Through Partnership With Inter Medico Following Health Canada Class III Licence For HemoScreen
PixCell Medical today announced its expansion into the Canadian market following the receipt of a Health Canada Class III Medical Device License for its HemoScreen™ point-of-care hematology analyzer and a new distribution partnership with Inter Medico.
- Onymos And Vanta Diagnostics Collaborate To Scale Intelligent Lab Intake
- Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader To Help Simplify Protein, Cell And Microbial Analysis
- Invivoscribe Begins Commercial Shipments Of PrepQuant Systems, Enabling High-Sensitivity Sample Preparation For MRD Testing
- New Peer-Reviewed Study Advances CIZ1B Blood Test For Early Lung Cancer Detection
ARCHIVED NEWSLETTER
- 08.25.26 -- GHK-Cu Peptide Launched By Kylo Peptides For Laboratory Research Applications
- 07.21.26 -- Reassessing Nanoparticle Immunotoxicity: From Well-Established To Novel Approaches
- 07.07.26 -- A Comparison Of 6 Analytical Validation Guidelines Using Data Envelopment Analysis
- 05.26.26 -- Engineering Repeat-Dose RNA: Engineering Around Immune Recognition In Repeat-Dose RNA Therapeutics
- 04.21.26 -- Proteomics Tools: A Resurrection